No Detail Found!

Frequency of Non-alcoholic Steatohepatitis on Histopathology in Patients of Type 2 Diabetes Mellitus with Duration of More Than 5 Years.

Author(s)
Naresh Kumar Seetlani Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Abdul Rauf Memon Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Sadia Tanveer Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Asif Ali Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Pyar Ali Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Khalid Imran Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Hussain Haroon Dow Medical College, Civil Hospital Karachi, DUHS Karachi, Pakistan
Abstract
Objective: To determine the frequency of non-alcoholic steatohepatitis (NASH) on histopathology in patients of type 2 diabetes mellitus with duration of more than 5 years. Study Design: Descriptive, cross-sectional study. Place and Duration of Study: Department of Medicine, Dow Medical College, Civil Hospital, Karachi, from November 2013 to April 2014. Methodology: Patients with type 2 diabetes mellitus of more than 5 years duration having raised alanine transaminases level and fatty liver on ultrasonography were selected. Informed consent was obtained and liver biopsy was performed in all patients by experienced physician of Civil Hospital Karachi. All samples of biopsy were sent for histopathology. Those patients with hepatitis B, C and D and steatosis like alcoholic and hypertriglyceridemia were excluded from the study. Descriptive statistics were calculated on SPSS version 17. Results: Out of the 262 cases, 56.49% (148/262) showed non-alcoholic steatohepatitis on the basis of histopathology. The mean age of the patients was 50.72 ±8.48 years. Median (interquartile) duration of diabetes mellitus of the cases was 9 years (15 - 4). Out of 148 NASH cases, 56.1% (83/148) were males and 43.9% (65/148) were females. Conclusion: Nonalcoholic steatohepatitis is an increasingly important and unrecognised spectrum of chronic liver disease associated with high prevalence of diabetes that is often overlooked and diagnosed with complications. So early recognition of these patients can prevent further complications.
Publication Details
Page(s) 643-646
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 8, Year: 2016

Request the full text from PASTIC

Keywords
Nonalcoholic steatohepatitis (NASH). Non-Alcoholic Fatty Liver Disease (NAFLD). Diabetes mellitus. Hepatocellular carcinoma.
References
2010.[cited2013 June18], -
2010.Prevalence estimates of diabetes mellitus (DM), 2010 - MENA, -
SheraAS,JawadF,MaqsoodA, 2007.Prevalence of diabetes in Pakistan,Diabetes Res ClinPract 76 219 -22
FarrellGC,LarterCZ, 2006.Non-alcoholic fatty liver disease: From Steatosis to cirrhosis,Hepatology 43 S100 -12
ChalasaniN,YounossiZ,LavineJE,DiehlAM,BruntEM,CusiK, 2012.The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,Hepatology 55 2005 -23
PreissD,SattarN., 2008.Non-alcoholic fatty liver disease: An overview of prevalence, diagnosis, pathogenesis and treatment considerations,ClinSci (Lond) 115 141 -50
TolmanKG,FonsecaV,TanMH,DalpiazA, 2004.Narrative review: Hepatobiliary disease in type 2 diabetes mellitus,Ann Intern Med 141 946 -56
GupteP,AmarapurkarD,AgalS,BaijalR,KulshresthaP,PramanikS, 2004.Non-alcoholic steatohepatitis in type 2 diabetes mellitus,J Gastroenterol Hepatol 19 854 -8
PrashanthM,GaneshHK,VimaMV,JohnM,BandgarT,JoshiSR, 2009.Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus,J Assoc Physicians India 57 205 -10
KalraS,VithalaniM,GulatiG,KulkarniCM,KadamY,PallivathukkalJ, 2013.Study of prevalence of non-alcoholic fatty liver disease (NAFLD) in Type 2 diabetes patients in India,J Assoc Physicians India 61 448 -53
TaseerIH,HussainL,SafdarS,MirbaharAM,AhmadI., 2009.Frequency of non-alcoholic fatty liver disease (NAFLD) & its biochemical derangements in Type-2 diabetic patients,Pak J Med Sci 25 817 -20
AnsariA,BilalN., 2005.Frequency of non-alcoholic steatohepatitis (NASH) in type 2 Diabetes Mellitus,Ann Pak Inst Med Sci 1 227 -9
2001.Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III),JAMA 285 2486 -
ClarkJM,Diehl IS, 2003.Non-alcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis,JAMA 289 3000 -4
CollantesR,OngJP,YounossiZM, 2004.Non-alcoholic fatty liver disease and the epidemic of obesity,Cleve Clin J Med 71 657 -64
ByronD,MinukG., 1996.Clinical hepatology: Profile of an urban, hospital-based practice,Hepatology 24 813 -5
JimbaS,NakagamiT,TakahashiM,WakamatsuT,HirotaY,IwamotoY,WasadaT., 2005.Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults,Diabet Med 22 1141 -5
SchaffnerF,ThalerH, 1986.Non-alcoholic fatty liver disease,Prog Liver Dis 8 283 -98
SilvermanJF,O'BrienKF,LongS., 1990.Liver pathology in morbid obese patients with and without diabetes,Am J Gastroenterol 85 1349 -55
BaconBR,FarahvashMJ,JanneyCG,Neuschwander-TetriBA, 1994.Non-alcoholic steatohepatitis-an expanded clinical entity,Gastroenterology 107 1103 -9
UygunA,KadayifciA,IsikAT, 2004.Metformin in the treatment of patients with non-alcoholic steatohepatitis,Aliment Pharmacol Ther 19 537 -44
ReinesHD,GoodmanZ,YounossiZM, 2005.Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients,Obes Surg 15 310 -5
BeymerC,KowdleyKV,LarsonA,EdmonsonP,DellingerEP,FlumDR, 2003.Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery,Arch Surg 138 1240 -4
AmarapurkarDN,AmarapurkarAD,PatelND,AgalS,BaigalR,GupteP, 2006.Non-alcoholic steatohepatitis (NASH) with diabetes: Predictors of liver fibrosis,Ann Hepatol 5 30 -3
MarchesiniG,BugianesiE,ForlaniG,CerrelliF,LenziM,ManiniR, 2003.Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome,Hepatology 37 917 -23
0

Citations

0

Downloads

76

Views